Insights
News | Managed Healthcare Executive
Three Pharmacy Regulations Health Execs Should Watch
Karen Appold
June 5, 2018
Edward Buthusiem comments on the Orphan Drug Act designation and its benefits and incentives; the volume and costs of producing and selling orphan drugs; and the pending Closing Loopholes for Orphan Drugs Act.